Aspirin Use, Dose, and Clinical Outcomes in Postmenopausal Women with Stable Cardiovascular Disease: The Women’s Health Initiative Observational Study

BACKGROUND: Despite compelling evidence that aspirin reduces fatal and non-fatal vascular events among the overall population in various settings, women have frequently been underrepresented and their data underreported. We sought to evaluate the relationship between aspirin use, dose (81 or 325mg)...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Berger, Jeffrey S, Brown, David L, Burke, Gregory L, Oberman, Albert, Kostis, John B, Langer, Robert D, Wong, Nathan D, Wassertheil-Smoller, Sylvia
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2801891/
https://ncbi.nlm.nih.gov/pubmed/20031819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.108.791269
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires